CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for 4Basebio AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

4Basebio AG
Waldhofer Str. 102
Phone: +49 62213540120p:+49 62213540120 Heidelberg, 69123  Germany Fax: +49 62213540127f:+49 62213540127

Business Summary
4Basebio AG, formerly Expedeon AG, is a Germany-based biotechnology company. The Company develops and markets molecular-diagnostic technologies, such as in field of deoxyribonucleic acid (DNA) amplification and sequencing. The Company's solutions are used in drug discovery research and diagnostic product development and include TruePrime whole genome amplification technology, the Lightning-Link antibody labeling technology, the CaptSure single-step antibody capture technology, the RunBlue Bis Tris gels for electrophoresis, and colloidal gold nanoparticles for point of care lateral flow assays, such as pregnancy testing, among others. In addition, the Company offers custom services, such as antibody and particle conjugation, as well as delivers bulk orders. The Company operates through subsidiaries in Germany, Spain, Australia, Singapore, the United Kingdom and the United States.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20053/31/2005YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Supervisory Board Joseph M.Fernandez 7/9/2019 10/17/2012
Chief Executive Officer, Chief Scientific Officer, Member of the Management Board HeikkiLanckriet 7/7/2017 8/1/2016
Chief Financial Officer, Member of the Management Board DavidRoth 3/1/2017 3/1/2017
5 additional Officers and Directors records available in full report.

Business Names
Business Name
C.B.S. Scientific Company, Inc.
LION Bioscience AG

General Information
Number of Employees: 53 (As of 6/30/2005)
Outstanding Shares: 2,483,771 (As of 12/6/2012)
Shareholders: 456
Stock Exchange: NASD
Fax Number: +49 62213540127
Email Address: frank.lansky@lionbioscience.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023